Project Grant R01DE033991

Award Date 4/16/25
Completion Date 3/31/30
Dollars Obligated $558K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award of $565,228, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program, aims to identify cell surface markers and develop strategies for harnessing periodontal ligament stem cells (PDLSCs) to induce endogenous periodontal regeneration. The research, conducted by the University of Pittsburgh from August 2024 to May 2029, seeks to characterize the human homologs of mouse...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) totals $588,952 and will run from April 2025 to March 2030. The funding will support the development and optimization of a bio-inspired tubular matrix scaffold to guide the formation of periodontal ligament (PDL) principal fibers and rebuild the microenvironment for the regeneration of Sharpey's fibers, which are critical for...
This $241,500 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121) will fund research to identify diffusible small molecules that regulate the replication of the oral bacterium Porphyromonas gingivalis (P. gingivalis). The research aims to establish the identity of growth-promoting cues produced by different strains of P. gingivalis and the early biofilm colonizer Veillonella...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $248,999 to investigate the role of CD4+ memory T cell subtypes in the recurrence of periodontal disease. The project aims to: 1) identify the spatiotemporal development of CD4+ memory T cells in periodontal tissues, 2) elucidate the pathogenicity of periodontal disease-induced CD4+ memory T cell subtypes, and 3) develop an...
This federal Project Grant award, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to investigate a novel regulator, DIN, that governs the regenerative capacity of murine teeth. The $346,938 award, with a performance period from September 12, 2024 to August 31, 2029, aims to determine DIN's role in regulating mesenchymal stem cell (MSC) homeostasis during tissue turnover and...
This Project Grant award, totaling $446,875.00, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The award supports research to investigate the role of a novel G protein-coupled receptor (MRGPRX2/MRGPRB2) expressed on mast cells and its contribution to the development of periodontal disease. The research aims to develop humanized mouse models to study the impact of this receptor and its...
This $2,055,996 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund a research program led by Dr. Noriaki Ono at the University of Texas Health Science Center at Houston (UTHealth) to investigate skeletal stem cell plasticity in craniofacial bone diseases. The research program consists of three interconnected projects: Examining the roles of periosteal and endosteal stem cells...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $873,546 Project Grant under the Oral Diseases and Disorders Research Program (CFDA 93.121) to the University of Texas Health Science Center at Houston (UTHealth). The grant aims to develop a biomaterial-enhanced system for targeted localization of engineered probiotic bacteria (Limosilactobacillus reuteri) that secrete the anti-inflammatory cytokine interleukin-10 (IL-10) to treat experimental periodontitis. The key...
This Project Grant award of $1,839,472 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to define dysbiosis and identify microbial changes that are predictive of periodontitis progression and stability. The project aims to utilize the biobank and longitudinal data from the previous "Biomarkers of Periodontal Disease Progression (BPDP)" study to examine microbial,...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $432,209 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) program to the University of California, Los Angeles (UCLA) for a 2-year period starting on August 1, 2023. The funding supports research to investigate the role of the CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus on periodontitis. Specifically, the research aims to further elucidate the role of CXCL10 in the...

This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), totaling $557,606.00, supports research aimed at advancing the understanding of periodontal stem cells and their regulation for more predictable and efficient periodontal tissue regeneration.

The key research objectives are to: 1) characterize the properties of periodontal crestal stem cells (PCSCs) and their activation by injury; 2) determine the signaling pathways regulating PCSC activation and lineage-specific differentiation during periodontal tissue repair; and 3) evaluate the roles of CXCL12 and SHH in periodontal tissue regeneration in a periodontitis mouse model. The award will be used to conduct comprehensive scientific investigations, including molecular and cellular studies, tissue engineering research, and in vivo experiments, with the goal of developing new insights into periodontal stem cell biology and advancing treatment approaches for periodontal diseases. The award period runs from April 16, 2025 to March 31, 2030.

Generated 4/29/25, 1:50 AM